Improvement of debilitating tardive dyskinesia with risperidone.
This case vignette illustrates dramatic improvement of tardive dyskinesia (TD) in an elderly female with a long history of neuroleptic exposure, following treatment with low-dose risperidone. The TD continued to be in remission at 1-year follow-up. This observation calls for well-designed randomized studies to evaluate the efficacy of risperidone in treating TD.
Rangwani
S R
SR
Creighton-Nebraska Department of Psychiatry, Omaha 68198-5575, USA.
Gupta
S
S
Burke
W J
WJ
Potter
J
J
D000368:Aged; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy*; D005260:Female; D006801:Humans; D018967:Risperidone / Q000494:pharmacology / Q000627:therapeutic use*
D014150:Antipsychotic Agents; D018967:Risperidone